Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women

Covid19 Clinical Trial

Official title:

Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04629638
• Other study ID #: maternalattachmentcovid
• Status: Completed
• Start date: August 1, 2020
• Est. completion date: November 20, 2020

Study information

• Verified date: December 2020
• Source: Kanuni Sultan Suleyman Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Maternal attachment, Edinburgh depression scoring, and postpartum anxiety scale are evaluated in patients with covid-positive pregnancies in the 3rd month after birth.

Description:

Maternal attachment, Edinburgh depression scoring and postpartum anxiety scale are evaluated in 250 covid-positive pregnant women in the 3rd month after birth. The results will be compared with the results of covid-negative pregnant women who gave birth in the same period.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 500
• Est. completion date: November 20, 2020
• Est. primary completion date: November 15, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• covid -19 positive and negative pregnant women

• have no psychiatric illness

• not using antidepressants or antipsychotic drugs

Exclusion Criteria:

• women with psychiatric illness

• using antidepressants or antipsychotic drugs

• not pregnant

• adolescent pregnancy

Related Conditions & MeSH terms

• Anxiety Disorders
• Covid19
• Depression
• Depression, Anxiety
• Depressive Disorder
• Pregnancy Related

Intervention

Other:
• Maternal attachment, Edinburgh depression scoring and postpartum anxiety scale scores
The results will be compared with the results of covid-negative pregnant women who gave birth in the same period.

Locations

Country	Name	City	State
Turkey	Pinar Yalcin Bahat	Istanbul	I?stanbul

Sponsors (1)

Lead Sponsor	Collaborator
Kanuni Sultan Suleyman Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Maternal attachment in SARS- cov2 positive and negative pregnant women	Maternal attachment scores evaluated in 250 covid-positive pregnant women in the 3rd month after birth. The results will be compared with the results of covid-negative pregnant women who gave birth in the same period. High scores from the scale indicate high maternal attachment.	3 months
Primary	Edinburgh depression scores in in SARS- cov2 positive and negative pregnant women	Edinburgh depression scores evaluated in 250 covid-positive pregnant women in the 3rd month after birth. The results will be compared with the results of covid-negative pregnant women who gave birth in the same period. All questions are scored between 0 and 3 and the highest possible score on the scale is 30. and shows advanced depression.	3 months
Primary	Postpartum anxiety scale scores in in SARS- cov2 positive and negative pregnant women	Postpartum anxiety scale scores evaluated in 250 covid-positive pregnant women in the 3rd month after birth. The results will be compared with the results of covid-negative pregnant women who gave birth in the same period. It can be said that the postpartum anxiety levels of those who score 73 and below on the scale are low, those who score between 74 and 100 are medium, and those who score 101 and above are high.	3 months